MYLAN 1730 MYLAN 1730 (Ursodiol 300 mg)
Pill with imprint MYLAN 1730 MYLAN 1730 is Peach & White, Capsule-shape and has been identified as Ursodiol 300 mg. It is supplied by Mylan Pharmaceuticals Inc..
Ursodiol is used in the treatment of primary biliary cholangitis ; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 1730 MYLAN 1730
Ursodiol
- Imprint
- MYLAN 1730 MYLAN 1730
- Strength
- 300 mg
- Color
- Peach & White
- Size
- 23.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Gallstone solubilizing agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
corn starch,
FD&C Yellow No. 6,
gelatin,
hydroxypropyl cellulose (type h),
magnesium stearate,
microcrystalline cellulose,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
titanium dioxide,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-1730 | Mylan Pharmaceuticals Inc. |
| 51079-0383 | UDL Laboratories Inc. |
More about ursodiol
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 23 Reviews
- Drug class: gallstone solubilizing agents
Patient resources
- Other brands
- Actigall, Urso, Urso Forte, Reltone
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.